Internal Medicine, Pulmonary Disease · Lubbock, TX
NPI
1144282351
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
Texas Tech Physicians, 3601 4th Street Stop 9410
Lubbock, TX, 79430
Phone (806) 743-3150
Groups this clinician bills Medicare through
Medicare paid, 2024
$102K
1,600 services
Medicare patients, 2024
326
Average age 73
Drug cost, 2024
$13.3M
2,653 prescriptions
Company payments, 2025
$286
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Victor J Test was code 99214 (office e&m - established), 267 times for 128 patients. In total Victor J Test billed 1,600 services in 55 codes, and Medicare paid $102K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 267 | 128 | $93.87 | $25K |
| 99232 Hospital E&M - Subsequent | Facility | 244 | 75 | $58.26 | $14K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 202 | 114 | $12.18 | $2,461 |
| 99233 Hospital E&M - Subsequent | Facility | 167 | 62 | $89.82 | $15K |
| 94618 Pulmonary Function Testing | Office | 101 | 74 | $23.48 | $2,372 |
| 99213 Office E&M - Established | Office | 62 | 49 | $64.40 | $3,992 |
| 99291 Critical Care E&M | Facility | 61 | 27 | $155.74 | $9,500 |
| 99223 Hospital E&M - Initial | Facility | 49 | 47 | $127.34 | $6,240 |
| 94726 Pulmonary Function Testing | Facility | 49 | 49 | $8.54 | $418 |
| 93451 Percutaneous Transcatheterization | Facility | 48 | 42 | $94.02 | $4,513 |
| 94729 Pulmonary Function Testing | Facility | 48 | 48 | $6.33 | $304 |
| 99222 Hospital E&M - Initial | Facility | 40 | 37 | $97.19 | $3,887 |
| 94010 Pulmonary Function Testing | Facility | 35 | 35 | $5.82 | $204 |
| 99204 Office E&M - New | Office | 30 | 29 | $127.04 | $3,811 |
| 93463 Percutaneous Transcatheterization | Facility | 22 | 22 | $73.31 | $1,613 |
By year: 2022 $91K for 1,128 services; 2023 $84K for 1,261 services; 2024 $102K for 1,600 services.
Medicare prescription drug claims, 2024
In 2024, the drug Victor J Test prescribed most often to Medicare patients was Opsumit (Macitentan), with 279 prescriptions and refills. In total Victor J Test wrote 2,653 Medicare prescriptions that cost $13.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Opsumit Macitentan | 279 | 291 | 40 | $3.7M |
| Spironolactone Generic | 203 | 454 | 58 | $2,020 |
| Jardiance Empagliflozin | 184 | 240 | 36 | $134K |
| Tyvaso Dpi Treprostinil | 179 | 179 | 28 | $4.4M |
| Furosemide Generic | 173 | 415 | 59 | $1,367 |
| Tadalafil Generic | 151 | 181 | 28 | $247K |
| Sildenafil Citrate Generic | 134 | 202 | 32 | $35K |
| Ambrisentan Generic | 95 | 125 | 16 | $582K |
| Uptravi Selexipag | 71 | 71 | Under 11 | $1.6M |
| Prednisone Generic | 68 | 105 | 24 | $524 |
| Mycophenolate Mofetil Generic | 63 | 109 | 16 | $11K |
| Pantoprazole Sodium Generic | 62 | 126 | 17 | $630 |
| Adempas Riociguat | 58 | 58 | Under 11 | $796K |
| Potassium Chloride Generic | 51 | 108 | 15 | $1,024 |
| Winrevair Sotatercept-Csrk | 50 | 50 | Under 11 | $875K |
Brand drugs: 1,142 claims; generic drugs: 1,511 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Victor J Test $286 ($286 in general payments such as food, travel and fees) from 6 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $200.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.